How to buy Inari Medical stock | $86.95

Inari Medical, Inc is a medical devices business based in the US. Inari Medical shares (NARI) are listed on the NASDAQ and all prices are listed in US Dollars. Inari Medical employs 456 staff and has a trailing 12-month revenue of around 0.00.

Inari Medical stock price (NASDAQ: NARI)

Use our graph to track the performance of NARI stocks over time.

Inari Medical shares at a glance

• Key figures

Information last updated 2021-07-28.

Latest market close	$86.95
52-week range	$55.58 - $127.42
50-day moving average	$91.45
200-day moving average	$99.62
Wall St. target price	$129.50
PE ratio	283.8291
Dividend yield	N/A (0%)
Earnings per share (TTM)	$0.32

Buy Inari Medical shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

*Signup bonus information updated weekly.

Is it a good time to buy Inari Medical stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of Inari Medical, Inc by TradingView

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Inari Medical price performance over time

Historical closes compared with the close of $86.95 from 2021-05-28

1 week (2021-07-22)	N/A
1 month (2021-07-02)	-9.30%
3 months (2021-04-30)	-23.92%
6 months (2021-01-29)	N/A

1 year (2020-07-29)	N/A
2 years (2019-07-29)	N/A
3 years (2018-07-29)	N/A
5 years (2016-07-29)	N/A

Is Inari Medical under- or over-valued?

Valuing Inari Medical stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Inari Medical's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Inari Medical's P/E ratio

Inari Medical's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 284x. In other words, Inari Medical shares trade at around 284x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

Inari Medical's EBITDA

Inari Medical's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $24.4 million.

The EBITDA is a measure of a Inari Medical's overall financial performance and is widely used to measure a its profitability.

Inari Medical financials

Revenue TTM	$170.1 million
Operating margin TTM	13.31%
Gross profit TTM	$127.8 million
Return on assets TTM	9.62%
Return on equity TTM	14.6%
Profit margin	10.08%
Book value	$4.31
Market capitalisation	$4.5 billion

TTM: trailing 12 months

Shorting Inari Medical shares

There are currently 1.3 million Inari Medical shares held short by investors – that's known as Inari Medical's "short interest". This figure is 8.2% down from 1.4 million last month.

There are a few different ways that this level of interest in shorting Inari Medical shares can be evaluated.

Inari Medical's "short interest ratio" (SIR)

Inari Medical's "short interest ratio" (SIR) is the quantity of Inari Medical shares currently shorted divided by the average quantity of Inari Medical shares traded daily (recently around 512505.22088353). Inari Medical's SIR currently stands at 2.49. In other words for every 100,000 Inari Medical shares traded daily on the market, roughly 2490 shares are currently held short.

However Inari Medical's short interest can also be evaluated against the total number of Inari Medical shares, or, against the total number of tradable Inari Medical shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Inari Medical's short interest could be expressed as 0.03% of the outstanding shares (for every 100,000 Inari Medical shares in existence, roughly 30 shares are currently held short) or 0.0385% of the tradable shares (for every 100,000 tradable Inari Medical shares, roughly 39 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Inari Medical.

Find out more about how you can short Inari Medical stock.

Inari Medical share dividends

We're not expecting Inari Medical to pay a dividend over the next 12 months.

Inari Medical overview

Inari Medical, Inc. , a commercial-stage medical device company, focuses on developing products to treat and transform the lives of patients suffering from venous diseases in the United States. It offers ClotTriever for treatment of deep vein thrombosis; and FlowTriever, a thrombectomy system for treatment of pulmonary embolism. The company was formerly known as Inceptus Newco1 Inc. and changed its name to Inari Medical, Inc. in September 2013. Inari Medical, Inc.

Frequently asked questions

What percentage of Inari Medical is owned by insiders or institutions?
Currently 24.125% of Inari Medical shares are held by insiders and 67.765% by institutions. How many people work for Inari Medical?
Latest data suggests 456 work at Inari Medical. When does the fiscal year end for Inari Medical?
Inari Medical's fiscal year ends in December. Where is Inari Medical based?
Inari Medical's address is: 9 Parker, Irvine, CA, United States, 92618 What is Inari Medical's ISIN number?
Inari Medical's international securities identification number is: US45332Y1091